Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
FDMT - TOTAL CURRENT ASSETS
Total Current Assets FDMT - 4D Molecular Therapeutics, Inc.
297 M
LAST VALUE
-3.03%
2 YEAR CAGR
25.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR